A protein tyrosine phosphatase inhibitor accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano
Masahiro
M
Department of Molecular and Cellular Biology, Division of Molecular and Clinical Gerontology, Medical Institute of Bioregulation, Kyushu University, Oita 874-0838, Japan. massy@tsurumi.beppu.kyushu-u.ac.jp
Tsuchida
Keiko
K
Makino
Naoki
N
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology*; D000818:Animals; D015153:Blotting, Western; D004195:Disease Models, Animal; D004789:Enzyme Activation; D006614:Hindlimb / Q000098:blood supply*; D007511:Ischemia / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism; D018919:Neovascularization, Physiologic; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors*; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D014638:Vanadates / Q000494:pharmacology*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism
D043925:Angiogenesis Inducing Agents; D014638:Vanadates; D040301:Vascular Endothelial Growth Factor Receptor-2; D017027:Protein Tyrosine Phosphatases